Toyota|$17.78 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.86 (¥4,271)-1.13%▼ (in JPY terms)
SoftBank|$20.63 (¥3,281)-3.95%▼ (in JPY terms)
MUFG|$20.67 (¥3,287)-3.75%▼ (in JPY terms)
Keyence|$456.00 (¥72,510)-1.28%▼ (in JPY terms)
Nintendo|$56.13 (¥8,926)+0.36%▲ (in JPY terms)
NTT|$1.07 (¥170)+0.77%▲ (in JPY terms)
Takeda|$43.59 (¥6,931)-0.09%▼ (in JPY terms)
Tokyo Electron|$54.44 (¥8,657)-1.56%▼ (in JPY terms)
Recruit|$114.42 (¥18,195)+5.02%▲ (in JPY terms)
ITOCHU|$14.68 (¥2,334)-2.59%▼ (in JPY terms)
Honda|$11.30 (¥1,797)-2.10%▼ (in JPY terms)
Shin-Etsu|$35.05 (¥5,574)-0.85%▼ (in JPY terms)
Tokio Marine|$3.67 (¥584)-2.23%▼ (in JPY terms)
Fast Retailing|$530.77 (¥84,400)+0.79%▲ (in JPY terms)
Toyota|$17.78 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.86 (¥4,271)-1.13%▼ (in JPY terms)
SoftBank|$20.63 (¥3,281)-3.95%▼ (in JPY terms)
MUFG|$20.67 (¥3,287)-3.75%▼ (in JPY terms)
Keyence|$456.00 (¥72,510)-1.28%▼ (in JPY terms)
Nintendo|$56.13 (¥8,926)+0.36%▲ (in JPY terms)
NTT|$1.07 (¥170)+0.77%▲ (in JPY terms)
Takeda|$43.59 (¥6,931)-0.09%▼ (in JPY terms)
Tokyo Electron|$54.44 (¥8,657)-1.56%▼ (in JPY terms)
Recruit|$114.42 (¥18,195)+5.02%▲ (in JPY terms)
ITOCHU|$14.68 (¥2,334)-2.59%▼ (in JPY terms)
Honda|$11.30 (¥1,797)-2.10%▼ (in JPY terms)
Shin-Etsu|$35.05 (¥5,574)-0.85%▼ (in JPY terms)
Tokio Marine|$3.67 (¥584)-2.23%▼ (in JPY terms)
Fast Retailing|$530.77 (¥84,400)+0.79%▲ (in JPY terms)

2026-06-03 Kirin Holdings Company,Limited “The results of a trial of ziftomenib in combination with venetoclax/azacitidine in patients with NPM1 mutation-induced relapsed/refractory AML have been published in the journal "Blood".”

2026-06-03 Kirin Holdings Company,Limited “The results of a trial of ziftomenib in combination with venetoclax/azacitidine in patients with NPM1 mutation-induced relapsed/refractory AML have been published in the journal "Blood".”

コメントする